Oscar Health (OSCR) to Release Quarterly Earnings on Tuesday

Oscar Health (NYSE:OSCR) will be announcing its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.28 per share for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Investors that are interested in registering for the company’s conference call can do so using this link.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, topping the consensus estimate of ($0.74) by $0.08. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The firm’s revenue was up 43.9% compared to the same quarter last year. During the same quarter last year, the firm posted ($1.05) EPS. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oscar Health Trading Down 0.9 %

OSCR stock opened at $17.40 on Tuesday. The company has a market capitalization of $4.00 billion, a PE ratio of -14.50 and a beta of 1.79. Oscar Health has a 12 month low of $4.72 and a 12 month high of $18.55. The firm’s 50-day moving average is $15.23 and its 200 day moving average is $11.41. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.19 and a quick ratio of 1.19.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several recent analyst reports. TheStreet raised shares of Oscar Health from a “d” rating to a “c-” rating in a research note on Wednesday, February 21st. Wells Fargo & Company raised their price target on shares of Oscar Health from $12.00 to $20.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. The Goldman Sachs Group raised their price target on shares of Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a research note on Friday, February 9th. Finally, Raymond James initiated coverage on shares of Oscar Health in a research note on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price target on the stock. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $13.50.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.